Abbott Laboratories buy Piper Sandler
Start price
17.10.24
/
50%
€109.48
Target price
17.10.25
€122.61
Performance (%)
4.14%
Price
04.07.25
€113.44
Summary
This prediction is currently active. With a performance of 4.14%, the BUY prediction by Piper_Sandler for Abbott Laboratories is trending in the right direction. Dividends of €0.57 are taken into consideration when calculating the performance. This prediction currently runs until 17.10.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -1.150% | -1.150% |
| iShares Core DAX® | -1.315% | -2.266% |
| iShares Nasdaq 100 | 0.272% | 1.449% |
| iShares Nikkei 225® | -2.496% | 1.560% |
| iShares S&P 500 | 0.504% | 1.340% |
Comments by Piper_Sandler for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Piper Sandler from $131.00 to $133.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Piper_Sandler for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€116.00
17.04.25
17.04.25
€127.60
17.04.26
17.04.26
-2.21%
04.07.25
04.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.70
19.09.24
19.09.24
€117.72
19.09.25
19.09.25
10.43%
04.07.25
04.07.25